Neuron navigator 3 alterations in nervous system tumors associate with tumor malignancy grade and prognosis

Genes Chromosomes and Cancer

Volumn 52, Issue 2, 2013, Pages 191-201

  Carlsson, Emilia ^a   Krohn, Kai ^b,c   Ovaska, Kristian ^d   Lindberg, Pia ^c   Häyry, Valtteri ^e   Maliniemi, Pilvi ^a   Lintulahti, Anu ^a   Korja, Miikka ^a,f   Kivisaari, Riku ^a   Hussein, Samer ^e   Sarna, Seppo ^d   Niiranen, Kirsi ^a   Hautaniemi, Sampsa ^d   Haapasalo, Hannu ^b   Ranki, Annamari ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c CliniXion Oy   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e UNIVERSITY OF HELSINKI   (Finland)

^f UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; GONADORELIN; JANUS KINASE; NEURON NAVIGATOR 3 PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER PROGNOSIS; CENTRAL NERVOUS SYSTEM TUMOR; CONTROLLED STUDY; COPY NUMBER VARIATION; EPENDYMOMA; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MEDULLOBLASTOMA; MICROARRAY ANALYSIS; NERVOUS SYSTEM TUMOR; NEUROBLASTOMA; OLIGODENDROGLIOMA; PERIPHERAL NERVOUS SYSTEM TUMOR; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SURVIVAL; UPREGULATION;

CELL LINE, TUMOR; COMPARATIVE GENOMIC HYBRIDIZATION; DNA COPY NUMBER VARIATIONS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; KAPLAN-MEIER ESTIMATE; MEDULLOBLASTOMA; MEMBRANE PROTEINS; NERVE TISSUE PROTEINS; NERVOUS SYSTEM NEOPLASMS; NEUROBLASTOMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECEPTORS, INTERLEUKIN; RECEPTORS, LHRH; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR MARKERS, BIOLOGICAL;

EID: 84871091676     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22019     Document Type: Article

References (39)

1. Allen M, Louise Jones J. 2011. Jekyll and Hyde: The role of the microenvironment on the progression of cancer. J Pathol 223: 162-176.
2. Baryawno N, Sveinbjornsson B, Eksborg S, Chen CS, Kogner P, Johnsen JI. 2010. Small-molecule inhibitors of phosphatidylinositol 3-kinase/Akt signaling inhibit Wnt/beta-catenin pathway cross-talk and suppress medulloblastoma growth. Cancer Res 70: 266-276.
3. Bredel M, Scholtens DM, Harsh GR, Bredel C, Chandler JP, Renfrow JJ, Yadav AK, Vogel H, Scheck AC, Tibshirani R, Sikic BI. 2009. A network model of a cooperative genetic landscape in brain tumors. J Am Med Assoc 302: 261-275.
4. Cancer Genome Atlas Research Network. 2008. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455: 1061-1068.
5. Caricasole A, Bakker A, Copani A, Nicoletti F, Gaviraghi G, Terstappen GC. 2005. Two sides of the same coin: Wnt signaling in neurodegeneration and neuro-oncology. Biosci Rep 25: 309-327.
6. Carlsson E, Ranki A, Sipila L, Karenko L, Abdel-Rahman WM, Ovaska K, Siggberg L, Aapola U, Assamaki R, Hayry V, Niiranen K, Helle M, Knuutila S, Hautaniemi S, Peltomaki P, Krohn K. 2012. Potential role of a navigator gene NAV3 in colorectal cancer. Br J Cancer 106: 517-524.
7. Coy JF, Wiemann S, Bechmann I, Bachner D, Nitsch R, Kretz O, Christiansen H, Poustka A. 2002. Pore membrane and/or filament interacting like protein 1 (POMFIL1) is predominantly expressed in the nervous system and encodes different protein isoforms. Gene 290: 73-94.
8. Gadde S, Heald R. 2004. Mechanisms and molecules of the mitotic spindle. Curr Biol 14: R797-R805.
9. Gardner S, Pawson AJ. 2009. Emerging targets of the GnRH receptor: Novel interactions with Wnt signalling mediators. Neuroendocrinology 89: 241-251.
10. Gertz EM, Sengupta K, Difilippantonio MJ, Ried T, Schaffer AA. 2009. Evaluating annotations of an Agilent expression chip suggests that many features cannot be interpreted. Biomed Chromatogr Genomics 10: 566.
11. Hahtola S, Burghart E, Jeskanen L, Karenko L, Abdel-Rahman WM, Polzer B, Kajanti M, Peltomaki P, Pettersson T, Klein CA, Ranki A. 2008a. Clinicopathological characterization and genomic aberrations in subcutaneous panniculitis-like T-cell lymphoma. J Invest Dermatol 128: 2304-2309.
12. Hahtola S, Burghart E, Puputti M, Karenko L, Abdel-Rahman WM, Vakeva L, Jeskanen L, Virolainen S, Karvonen J, Salmenkivi K, Kinnula V, Joensuu H, Peltomaki P, Klein CA, Ranki A. 2008b. Cutaneous T-cell lymphoma-associated lung cancers show chromosomal aberrations differing from primary lung cancer. Genes Chromosomes Cancer 47: 107-117.
13. Jin S, Sun C, Yu S, Wang Q, Wu W, Sun Y, Zhao W, An T. 2010. Chromosome DNA imbalances in human astrocytic tumors: A comparative genomic hybridization study of 63 Chinese patients. Pathol Res Pract 206: 674-681.
14. Karenko L, Hahtola S, Paivinen S, Karhu R, Syrja S, Kahkonen M, Nedoszytko B, Kytola S, Zhou Y, Blazevic V, Pesonen M, Nevala H, Nupponen N, Sihto H, Krebs I, Poustka A, Roszkiewicz J, Saksela K, Peterson P, Visakorpi T, Ranki A. 2005. Primary cutaneous T-cell lymphomas show a deletion or translocation affecting NAV3, the human UNC-53 homologue. Cancer Res 65: 8101-8110.
15. Kaverina I, Straube A. 2001. Regulation of cell migration by dynamic microtubules. Semin Cell Dev Biol 9: 968-974.
16. Klein C, Mikutta J, Krueger J, Scholz K, Brinkmann J, Liu D, Veerkamp J, Siegel D, Abdelilah-Seyfried S, le Noble F. 2011. Neuron navigator 3a regulates liver organogenesis during zebrafish embryogenesis. Development 138: 1935-1945.
17. Li Y, Chu N, Hu A, Gran B, Rostami A, Zhang GX. 2008. Inducible IL-23p19 expression in human microglia via p38 MAPK and NF-kappaB signal pathways. Exp Mol Pathol 84: 1-8.
18. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P. 2007. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114: 97-109.
19. Maes T, Barcelo A, Buesa C. 2002. Neuron navigator: A human gene family with homology to unc-53, a cell guidance gene from Caenorhabditis elegans. Genomics 80: 21-30.
20. Maliniemi P, Carlsson E, Kaukola A, Ovaska K, Niiranen K, Saksela O, Jeskanen L, Hautaniemi S, Ranki A. 2011. NAV3 copy number changes and target genes in basal and squamous cell cancers. Exp Dermatol 20: 926-931.
21. Marelli MM, Moretti RM, Mai S, Muller O, Van Groeninghen JC, Limonta P. 2009. Novel insights into GnRH receptor activity: Role in the control of human glioblastoma cell proliferation. Oncol Rep 21: 1277-1282.
22. Martinez-Lopez MJ, Alcantara S, Mascaro C, Perez-Branguli F, Ruiz-Lozano P, Maes T, Soriano E, Buesa C. 2005. Mouse neuron navigator 1, a novel microtubule-associated protein involved in neuronal migration. Mol Cell Neurosci 28: 599-612.
23. Merrill RA, Plum LA, Kaiser ME, Clagett-Dame M. 2002. A mammalian homolog of unc-53 is regulated by all-trans retinoic acid in neuroblastoma cells and embryos. Proc Natl Acad Sci USA 99: 3422-3427.
24. Nord H, Hartmann C, Andersson R, Menzel U, Pfeifer S, Piotrowski A, Bogdan A, Kloc W, Sandgren J, Olofsson T, Hesselager G, Blomquist E, Komorowski J, von Deimling A, Bruder CE, Dumanski JP, Diaz de Stahl T. 2009. Characterization of novel and complex genomic aberrations in glioblastoma using a 32K BAC array. Neuro-Oncology 11: 803-818.
25. Olshen AB, Venkatraman ES, Lucito R, Wigler M. 2004. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 5: 557-572.
26. Ovaska K, Laakso M, Haapa-Paananen S, Louhimo R, Chen P, Aittomaki V, Valo E, Nunez-Fontarnau J, Rantanen V, Karinen S, Nousiainen K, Lahesmaa-Korpinen AM, Miettinen M, Saarinen L, Kohonen P, Wu J, Westermarck J, Hautaniemi S. 2010. Large-scale data integration framework provides a comprehensive view on glioblastoma multiforme. Genome Med 2: 65.
27. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, Misra A, Nigro JM, Colman H, Soroceanu L, Williams PM, Modrusan Z, Feuerstein BG, Aldape K. 2006. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9: 157-173.
28. Ranki A, Vakeva L, Sipila L, Krohn K. 2011. Molecular markers associated with clinical response to bexarotene therapy in cutaneous T-cell lymphoma. Acta Derm Venereol 91: 568-573.
29. Riemenschneider MJ, Reifenberger G. 2009. Molecular neuropathology of gliomas. Int J Mol Sci 10: 184-212.
30. Salisbury TB, Binder AK, Nilson JH. 2008. Welcoming beta-catenin to the gonadotropin-releasing hormone transcriptional network in gonadotropes. Mol Endocrinol 22: 1295-1303.
31. Sareddy GR, Panigrahi M, Challa S, Mahadevan A, Babu PP. 2009. Activation of Wnt/beta-catenin/Tcf signaling pathway in human astrocytomas. Neurochem Int 55: 307-317.
32. Solimini NL, Xu Q, Mermel CH, Liang AC, Schlabach MR, Luo J, Burrows AE, Anselmo AN, Bredemeyer AL, Li MZ, Beroukhim R, Meyerson M, Elledge SJ. 2012. Recurrent hemizygous deletions in cancers may optimize proliferative potential. Science 337: 104-109.
33. Tabatabai G, Stupp R, van den Bent MJ, Hegi ME, Tonn JC, Wick W, Weller M. 2010. Molecular diagnostics of gliomas: The clinical perspective. Acta Neuropathol 120: 585-592.
34. Tu Y, Zhong Y, Fu J, Cao Y, Fu G, Tian X, Wang B. 2011. Activation of JAK/STAT signal pathway predicts poor prognosis of patients with gliomas. Med Oncol 28: 15-23.
35. Van Es JH, Glies RH, Clevers HC. 2001. The many faces of the tumor suppressor gene APC. Exp Cell Res 264: 126-134.
36. van Haren J, Draegestein K, Keijzer N, Abrahams JP, Grosveld F, Peeters PJ, Moechars D, Galjart N. 2009. Mammalian navigators are microtubule plus-end tracking proteins that can reorganize the cytoskeleton to induce neurite-like extensions. Cell Motil Cytoskel 66: 824-838.
37. Vermeer MH, van Doorn R, Dijkman R, Mao X, Whittaker S, van Voorst Vader PC, Gerritsen MJ, Geerts ML, Gellrich S, Soderberg O, Leuchowius KJ, Landegren U, Out-Luiting JJ, Knijnenburg J, Ijszenga M, Szuhai K, Willemze R, Tensen CP. 2008. Novel and highly recurrent chromosomal alterations in Sezary syndrome. Cancer Res 68: 2689-2698.
38. Wilson AC, Salamat MS, Haasl RJ, Roche KM, Karande A, Meethal SV, Terasawa E, Bowen RL, Atwood CS. 2006. Human neurons express type I GnRH receptor and respond to GnRH I by increasing luteinizing hormone expression. J Endocrinol 191: 651-663.
39. Yeung CM, An BS, Cheng CK, Chow BK, Leung PC. 2005. Expression and transcriptional regulation of the GnRH receptor gene in human neuronal cells. Mol Hum Reprod 11: 837-842.